Dr. Corey Saba is a graduate of Louisiana State University School of Veterinary Medicine.  She completed her medical oncology residency at the University of Wisconsin-Madison and has been employed by the University of Georgia since 2006.  She has been actively involved in the design and execution of over 40 clinical trials in dogs, cats, and horses, including the trials leading to the licensure of rabacfosadine, the first fully approved FDA treatment for canine lymphoma.  Her primary research interest is comparative oncology.